Search Results - "SCHWEISFURTH, H"

Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) : results of a multicentre randomized phase II trial by BINDER, D, SCHWEISFURTH, H, GRAH, C, SCHÄPER, C, TEMMESFELD -WOLLBRÜCK, B, SIEBERT, G, SUTTORP, N, BEINERT, T

“…Most patients (pts) with metastatic non-small cell lung cancer (NSCLC) receive either single agents or chemotherapy doublets. Recent studies have demonstrated…”
Get full text

Comparison of two budesonide powder inhalers, Easyhaler® and Turbuhaler®, in steroid-naïve asthmatic patients by SCHWEISFURTH, H, MALINEN, A, KOSKELA, T, TOIVANEN, P, RANKI-PESONEN, M

“…The objective of this multicenter study was to compare the clinical efficacy, safety, and acceptability of Easyhaler and Turbuhaler for the delivery of…”
Get full text

Phase III Study of Second-Line Chemotherapy for Advanced Non–Small-Cell Lung Cancer With Weekly Compared With 3-Weekly Docetaxel by SCHUETTE, Wolfgang, NAGEL, Sylke, REIFIIG, Angelika, SERKE, Monika, BLANKENBURG, Thomas, LAUTENSCHLAEGER, Christine, HANS, Klaus, SCHMIDT, Ernst-Wilhelm, DITTRICH, Ina, SCHWEISFURTH, Hans, VON WEIKERSTHAL, Ludwig Fischer, RAGHAVACHAR, Aruna

“…A phase III study to determine whether a weekly docetaxel schedule improves the therapeutic index compared with the classic 3-weekly schedule. Patients with…”
Get full text

Transfusion-related acute lung injury (TRALI) by Schweisfurth, H, Sopivnik, I, Moog, R

“…Transfusion-related acute lung injury (TRALI) is primarily caused by transfusion of fresh frozen plasma or platelet concentrates and occurs by definition…”
Get more information

Serum kininases I and II in patients with extrinsic and intrinsic asthma by Schweisfurth, H

Get more information

Pleural penetration of ciprofloxacin in patients with empyema thoracis by Morgenroth, A, Pfeuffer, H P, Seelmann, R, Schweisfurth, H

“…We evaluated the pharmacokinetics of a single 200-mg dose of ciprofloxacin, administered as a 30-minute infusion, into pleural exudate in five elderly patients…”
Get more information

Cost saving with ultrasonography in a developing country district hospital by Ali, Q M, Roth, J, Abdel-Rahim, I M, Franke, D, Kardorff, R, Schweisfurth, H, Doehring, E

“…To estimate the potential monetary reduction induced by the introduction of an ultrasound unit in a major district hospital in a developing country. Propective…”
Get more information

Serum angiotensin I converting enzyme in patients with cirrhosis of the liver in orthostasis and recumbency by Schweisfurth, H

Get full text

Absence of the left pulmonary artery in a young man with haemoptysis by Schweisfurth, H, Jachmann, M, Schoettes, C, Lorenz, H

“…We report the case of a white male aged 21 yrs, who was admitted for acute onset of haemoptysis. His past medical history was normal and he had not previously…”
Get more information

Angiotensin I converting enzyme in rat testis, epididymis and vas deferens under different conditions by Hohlbrugger, G, Schweisfurth, H, Dahlheim, H

“…Angiotensin I converting enzyme (ACE) was found in the testis, epididymis and vas deferens of rats. In tissue specimens without a prior washout of seminal…”
Get full text

Follow that key by Schweisfurth, H, Haeseler, K

Get more information

Carboxypeptidase N by Schweisfurth, H

Get more information

Kininase I and II activities in serum of patients with lung diseases by Schweisfurth, H, Schmidt, M, Reinhart, E, Brugger, E

“…In serum of 530 patients with various lung diseases and in 70 healthy control subjects, kininase I (E.C. 3.4.17.3) and kininase II (E.C. 3.4.15.1) were…”
Get more information

Angiotensin I converting enzyme in cerebrospinal fluid of patients with neurological diseases by Schweisfurth, H, Schiöberg-Schiegnitz, S, Kuhn, W, Parusel, B

“…The angiotensin I converting enzyme activity (kininase II, EC 3.4.15.1) was measured fluorimetrically in cerebrospinal fluid (CACE) of 154 patients with…”
Get full text

Juxtaglomerular angiotensin II formation by Burghardt, W, Schweisfurth, H, Dahlheim, H

“…Previous studies have indicated the existence of an unknown AII-forming enzyme (AFE) in the glomerular region. This investigation was undertaken to…”
Get more information

Efficacy and tolerability of a weekly schedule of docetaxel-cisplatin as first-line treatment for advanced non-small cell lung cancer (NSCLC) by Binder, D., Hackenthal, M., Graseck, L., Schweisfurth, H., Schäper, C., Krüll, M., Temmesfeld-Wollbrück, B., Suttorp, N., Beinert, T., Hellriegel, K.

“…Abstract only 18159 Background: Docetaxel-cisplatin, administered every 3 weeks, is an effective first-line chemotherapy for locally advanced or metastatic…”
Get full text

Acute intoxication of a hydrazine-like gas by 19 workers in a garbage dump by Schweisfurth, H, Schöttes, C

“…Nineteen workers (18 males, 1 female) of a garbage dump (mean age 39.9 years, range 19-58 years) were admitted to our hospital because of inhalation of a…”
Get more information

Tolerability of a weekly schedule of docetaxel-cisplatin as first-line treatment in patients with stage IIIB/IV non-small cell lung cancer (NSCLC) by Binder, D., Hackenthal, M., Graseck, L., Schweisfurth, H., Schäper, C., Temmesfeld-Wollbrück, B., Suttorp, N., Beinert, T., Hellriegel, K.

“…Abstract only 17112 Background: Recent trials have shown that the combination docetaxel-cisplatin is an effective first-line treatment in locally advanced or…”
Get full text

Value of determination of kininase II in bronchoalveolar lavage fluid by Schweisfurth, H, Schmidt, M, Leppert, R, Brugger, E, Maiwald, L

“…Kininase II (KII), identical with angiotensin-I-converting enzyme (E.C. 3.4.15.1) was characterized biochemically and assayed fluorimetrically in…”
Get more information

Report by the Scientific Working Group for Therapy of Lung Diseases: German Fibrosis Register with initial results by Schweisfurth, H

“…The aim of this study was to evaluate the occurrence of interstitial lung diseases (ILD) in Germany. Therefore members of the WATL developed a questionnaire…”
Get more information